Status:
UNKNOWN
Perfusion and Hypoxia Evaluation in Tumors Using 18F-FDG PET/CT
Lead Sponsor:
Harbin Medical University
Conditions:
Perfusion and Hypoxia
Eligibility:
All Genders
18-80 years
Brief Summary
Investigators want to use 18F-FDG PET/CT imaging to reflect tumor perfusion and hypoxia.
Detailed Description
Perfusion and hypoxia were independent prognositic parameters for tumor patients. Developing a method that can evaluate tumor perfusion and hypoxia noninvasively and conveniently was in urgent need. 1...
Eligibility Criteria
Inclusion
- solid tumor proved by pathology(d\>3.0cm);
- age\>18-year-old;
- 3\. Karnofsky performance status \>70;
- sign the informed consent.
Exclusion
- There are obvious metal implants near the tumor;
- Can not lie still for 15 minutes.
- Pregnancy.
Key Trial Info
Start Date :
November 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03373994
Start Date
November 1 2016
End Date
December 31 2020
Last Update
February 21 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yingying Sun
Harbin, Heil, China, 150028